RU94034011A - Method for treatment of psychic disturbance - Google Patents

Method for treatment of psychic disturbance

Info

Publication number
RU94034011A
RU94034011A RU94034011/14A RU94034011A RU94034011A RU 94034011 A RU94034011 A RU 94034011A RU 94034011/14 A RU94034011/14 A RU 94034011/14A RU 94034011 A RU94034011 A RU 94034011A RU 94034011 A RU94034011 A RU 94034011A
Authority
RU
Russia
Prior art keywords
psychic
disturbance
treatment
patient
devilish
Prior art date
Application number
RU94034011/14A
Other languages
Russian (ru)
Inventor
С.В. Санникова
С.С. Островка
Н.А. Павлова
Original Assignee
С.В. Санникова
С.С. Островка
Н.А. Павлова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by С.В. Санникова, С.С. Островка, Н.А. Павлова filed Critical С.В. Санникова
Priority to RU94034011/14A priority Critical patent/RU94034011A/en
Publication of RU94034011A publication Critical patent/RU94034011A/en

Links

Landscapes

  • Electrotherapy Devices (AREA)

Abstract

FIELD: phychiatry. SUBSTANCE: proposed method makes it possible to completely heal patient from psychic disturbance by purifying patient's brain from "devilish force" parasitically living therein. EFFECT: useful approach for psychiatry.

Claims (1)

Способ предназначен для полного вылечивания человека от психического расстройства посредством очистки мозга больного от паразитирующей в нем "дьявольской силы".The method is intended to completely cure a person of a mental disorder by cleaning the patient’s brain from the "devilish power" parasitizing in it.
RU94034011/14A 1994-09-16 1994-09-16 Method for treatment of psychic disturbance RU94034011A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94034011/14A RU94034011A (en) 1994-09-16 1994-09-16 Method for treatment of psychic disturbance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94034011/14A RU94034011A (en) 1994-09-16 1994-09-16 Method for treatment of psychic disturbance

Publications (1)

Publication Number Publication Date
RU94034011A true RU94034011A (en) 1997-04-20

Family

ID=48432523

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94034011/14A RU94034011A (en) 1994-09-16 1994-09-16 Method for treatment of psychic disturbance

Country Status (1)

Country Link
RU (1) RU94034011A (en)

Similar Documents

Publication Publication Date Title
RU94038043A (en) Use of the substituted adenine derivatives for multiple sclerosis treatment
DE3684190D1 (en) USE OF TETRAHYDROBIOPTERINES FOR PRODUCING A MEDICINE FOR TREATING CHILDREN'S AUTISM.
ID22689A (en) METHODS FOR ACTIVATING CELLS THAT PROVIDE HUMAN ANTIGENT PROPERTIES, ACTIVATED CELLS THAT INDICATE HUMAN ANTIGENT PROPERTIES, AND ITS USE
NZ292854A (en) Use of an photoactive compound to treat multiple sclerosis which is followed by light therapy
CA2250919A1 (en) Photopheresis treatment of leukocytes
ATE180976T1 (en) INSIZABLE LECITHIN GEL
DE69721006D1 (en) USE OF THE OWN MODIFIED OWN BLOOD FOR THE TREATMENT OF AUTOIMMUNE DISEASES
ATE338813T1 (en) METHOD FOR TUMOR TREATMENT USING ALLOACTIVATED HUMAN LYMPHOCYTES
RU94020410A (en) Method of vomiting treatment or prophylaxis in mammalian and human using the certain quinuclidine, piperidine, azanorbornane, ethylenediamine derivatives and related compounds
PL298890A1 (en) Sulfonylobenzyl substituted benzo- and pyridopyridones, method of obtaining sames and therapeutic agents containing them
DE69834724D1 (en) Treatment of bowel or bladder infections
EE04261B1 (en) Use of aminoadamantane compounds as immunoregulators
CA2270558A1 (en) Treatment of autoimmune diseases by photochemotherapy
TR199900527T2 (en) Use of benzopyranols for the treatment of neurological disorders.
RU94034011A (en) Method for treatment of psychic disturbance
DE69315162T2 (en) Use of L-carnitine and acyl-L-carnitine for the treatment of patients suffering from AIDS-related syndromes and of asymptomatic HIV-seropositive patients
DE68901172D1 (en) (-) - 2-PYRAZOLINE COMPOUND, THEIR OPTICAL UNLOCKING AND THERAPEUTIC AGENT FOR THE TREATMENT OF CEREBRAL VEGETABLE DISEASES, CONTAINING THIS COMPOUND AS AN ACTIVE INGREDIENT.
RU2107489C1 (en) Composition for treatment of inflammatory process in parodontium
ATE207353T1 (en) USE OF BENZYDAMINE TO TREAT MEDICAL CONDITIONS CAUSED BY TNF
DE59107405D1 (en) An imidazobenzodiazepine used to treat sleep disorders
HUT57749A (en) Process for producing pharmaceutical compositions suitable for treating pathological conditions concerning cerebral blood insufficiency and one special active ingredient
ATE150645T1 (en) USE OF BMY 14802 TO TREAT ANXIETY IN PATIENTS EXPERIENCING BENZODIAZEPINE WITHDRAWAL SYMPTOMS
DE69509318T2 (en) Hyperbaric pressure chamber for high pressure medical treatment with no structural obstacles
RU94027701A (en) Method of allergenic treatment
ATE136776T1 (en) USE OF HEPTASTIGMINE TO TREAT CEREBRAL ICTUS